Primary record
(+/-)-N-[2-[[Hydroxy-3-(4-hydroxy)propyl]amino]ethyl-4-morpholinecarboxamide hemifumarate salt
- 库存
- 1,713 克
- 纯度
- 99.2 %
- CAS
- 81801-12-9
化合物标识与属性
- CAS
- 81801-12-9
- PubChem CID
- 155774
- SMILES
- C1COCCN1C(=O)NCCNCC(COC2=CC=C(C=C2)O)O
- Canonical SMILES
- O=C(NCCNCC(O)COc1ccc(O)cc1)N1CCOCC1
名称与同义词
- Xamoterol
- Xamoterolum
- Xamoterol hemifumarate
- Corwin
- Xamoterolum [Latin]
- Carwin
- Xamtol
- Xamoterol (fumarate)
- Fumarate, Xamoterol
- Xamoterol (USAN)
- 81801-12-9
- XAMOTEROL FUMARATE
- Hemifumarate, Xamoterol
- XAMOTEROL [INN]
- XAMOTEROL [MI]
- XAMOTEROL [USAN]
- Prestwick0_000923
- Prestwick1_000923
- Prestwick2_000923
- Prestwick3_000923
- RefChem:195096
- 7HE0JQL703
- GlyTouCan:G23793AP
- UNII-7HE0JQL703
- ICI-118587
- DTXSID8045222
- Xamoterol [USAN:BAN:INN]
- Xamoterol [USAN:INN:BAN]
- D01OIK
- Monohydrobromide, Xamoterol
- XAMOTEROLHEMIFUMARATE
- Xamoterol fumarate [USAN]
- Xamoterol Maleate (2:1)
- AC1L4EY3
- Monohydrochloride, Xamoterol
- XAMOTEROL [WHO-DD]
- Lopac0_001259
- SCHEMBL64461
- BSPBio_000826
- DTXCID6025222
- GTPL538
- CHEBI:10055
- CHEMBL75753
- SPBio_003005
- BPBio1_000910
- C16H25N3O5
- orb1694838
- CTK9A1537
- C01CX07
- ICI-118,587
- DXPOSRCHIDYWHW-UHFFFAOYSA-N
- NCGC00016099-04
- HMS2089I13
- UNII-N87007N668
- G23793AP
- EINECS 277-319-9
- Tox21_110304
- BDBM50248358
- CID155774
- EBC-26649
- ICI118587
- MFCD00661103
- AKOS027420460
- C16-H25-N3-O5
- ZINC 01532364
- CCG-205333
- DB13781
- ICI 118587
- SB50140
- ICI 1185876
- NCGC00016099-03
- NCGC00016099-05
- NCGC00024897-02
- NCGC00024897-03
- 73210-73-8
- AM806653
- C16H25N3O5.1/2C4H4O4
- DA-02619
- CAS-81801-12-9
- HY-101327
- J304.911F
- LS-177652
- N-(2-((2-hydroxy-3-(4-hydroxyphenoxy)propyl)amino)ethyl)morpholine-4-carboxamide
- N-[2-[[2-hydroxy-3-(4-hydroxyphenoxy)propyl]amino]ethyl]morpholine-4-carboxamide
- AB00514723
- CS-0021161
- FT-0717367
- J3.731.223A
- C11775
- D06328
- AB00514723-05
- 4-Morpholinecarboxamide, N-(2-((2-hydroxy-3-(4-hydroxyphenoxy)propyl)amino)ethyl)-, (+-)-
- C16-H25-N3-O5.1/2C4-H4-O4
- EN300-18457256
- L000630
- SR-01000075155
- Q4021708
- SR-01000075155-1
- SR-01000075155-3
- (+-)-N-(2-((2-Hydroxy-3-(p-hydroxyphenoxy)propyl)amino)ethyl)-4-morpholinecarboxamide
- BRD-A59337442-051-05-3
- N-(2-{[2-hydroxy-3-(4-hydroxyphenoxy)propyl]amino}ethyl)morpholine-4-carboxamide
- 1229516-19-1
- ICI 118587; ICI-118587; ICI118587; Xamoterol hemifumarate; Xamtol
- N-[2-[[(2R)-2-Hydroxy-3-(4-hydroxyphenoxy)propyl]amino]ethyl]-4-morpholinecarboxamide
- N-[2-[[2-Hydroxy-3-(4-hydroxyphenoxy)propyl]amino]ethyl]-4-morpholinecarboxamide
- 1-(4-hydroxyphenoxy)-3-[2-(4-morpholinocarboxamido)ethylamino]-2-propanol
- (R)-N-(2-((2-Hydroxy-3-(4-hydroxyphenoxy)propyl)amino)ethyl)morpholine-4-carboxamide
- 1-(p-Hydroxyphenoxy)-3-[[2-[[(morpholino)carbonyl]amino]ethyl]amino]-2-propanol
- N-(2-((2-hydroxy-3-(4-hydroxyphenoxy)propyl)amino)ethyl)-4-morpholinecarboxamide
- N-(2-(2-hydroxy-3-(4-hydroxyphenoxy)propylamino)ethyl)morpholine-4-carboxamide
- rel-N-(2-{[(2R)-2-hydroxy-3-(4-hydroxyphenoxy)propyl]amino}ethyl)morpholine-4-carboxamide
- (+/-)-N-(2-((2-HYDROXY-3-(P-HYDROXYPHENOXY)PROPYL)AMINO)ETHYL)-4-MORPHOLINECARBOXAMIDE
- (+/-)-N-[2-[[Hydroxy-3-(4-hydroxy)propyl]amino]ethyl-4-morpholinecarboxamide hemifumarate salt
- 4-MORPHOLINECARBOXAMIDE, N-(2-((2-HYDROXY-3-(4-HYDROXYPHENOXY)PROPYL)AMINO)ETHYL)-, (+/-)-
- 69630-08-6
- Bis[N-[2-[[2-hydroxy-3-(4-hydroxyphenoxy)propyl]amino]ethyl]morpholine-4-carboxamide] fumarate